Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Werable Healthcare Devices market: $13.7 Bn against $2.6 Bn in 2023, about 5.2 times as large.
China grows faster: 21.3% a year, against 17.8%. The gap still grows from $11.1 Bn to $52.4 Bn by 2033.
Clinical research: 619 active trials in the US, 121 in China.
| Measure | ||
|---|---|---|
| Market size, 2023 | $13.7 Bn | $2.6 Bn |
| Market size, 2033 projected | $70.5 Bn | $18.1 Bn |
| Growth a year (CAGR) | 17.8% | 21.3% |
| Money added, 2023–2033 | $56.8 Bn | $15.5 Bn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $40 | $1.86 |
| Active clinical trials | 619 | 121 |
| Full report | US report | China report |
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Werable Healthcare Devices market: $13.7 Bn against $2.6 Bn in 2023, about 5.2 times as large.
China grows faster: 21.3% a year, against 17.8%. The gap still grows from $11.1 Bn to $52.4 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.